Retinol-binding protein 4 (RBP4) and prealbumin (PA) serum concentration and bioimpedance parameters as selected markers of nutritional status in children with nephrotic syndrome Authors: Martyna Jasielska, Agnieszka Jędzura, Piotr Adamczyk Published: 2025 ABSTRACT BackgroundNephrotic syndrome (NS) is a clinical condition that results from the renal loss of protein exceeding the body’s compensatory abilities. Dysproteinemia in the acute phase of the disease inevitably affects the nutritional status of children. It is unclear whether the situation will fully normalize in remission. The aim of the study was to assess the serum concentrations of retinol binding protein 4 (RBP4) and prealbumin (PA), as well as the body composition parameters in children with NS in remission in comparison to healthy counterparts.MethodsThirty nephrotic children at the age of 11.9 ± 4.6 years were enrolled and compared to healthy counterparts. RBP4 and PA serum concentrations together with selected basic biochemical parameters, were determined. Body composition parameters were determined based on the bioimpedance method using the Tanita MC-980MA device.ResultsIn NS children the mean RBP4 concentration was 42.6 ± 11.6 mg/l, and mean PA concentration was 540.1 ± 442.1 µg/ml, and those values did not differ significantly from those in the control group (42.0 ± 10.9 mg/l and 372.8 ± 107.9 µg/ml, respectively). RBP4 concentration correlated positively with the age of the studied patients, while PA was not associated with age. Both studied markers did not show significant differences depending on the remission status – maintained with immunosuppressive therapy vs. without active treatment, as well as on the categorization according to the clinical course – steroid-sensitive NS vs. frequently relapsing or steroid-dependent NS. Based on bioimpedance measurements, the parameters characterizing body composition did not differ between NS group and controls.ConclusionsRBP4 and PA, which can be considered as selected biochemical markers of nutritional status, as well as body composition measures based on the bioimpedance, do not indicate differences between children with remission of idiopathic NS and their healthy peers. Successful induction and maintenance of NS remission restores the assessed aspects of nutritional status of these children. Introduction Nephrotic syndrome (NS) is a clinical condition that results from the renal loss of protein, primarily albumin, exceeding the body’s compensatory abilities. Increased protein excretion in the urine is caused by increased permeability of the glomerular filtration membrane as a result of various pathological factors or defects in its microstructure [1]. On average, the first onset of NS in children is diagnosed at the age of 3 years and the range between 2 and 6 years is considered to be typical [1]. This is also the time of intensive growth and body development, as well as the time when later preferences and eating habits are formed [2]. Steroids are the primary treatment for NS, as the disease can have a chronic relapsing course, its complications arise mainly from the effects of long-term or frequent use of steroids [1]. Eating and body composition disorders in NS may result from the disease process itself (i.e. protein loss in urine), poor nutrition, patients’ frequent self-restriction of physical activity, and the use of glucocorticosteroids in the treatment of NS [3]. It is known that children with chronic kidney disease (CKD) accompanied by reduced glomerular filtration rate are at risk of protein-energy malnutrition, but in patients with NS, renal filtration function is usually normal [1, 3]. Few studies in the available literature assess the nutritional status of patients with NS. The studies that have been conducted most often indicate that children undergoing glucocorticoid therapy have excessive body weight [4]. On the other hand, NS treatments such as glucocorticoids, improper diets, and low physical activity can lead to weight gain and subsequently increase the risk of cardiovascular disease later in life. Studies increasingly suggest that increased body fat, rather than high body mass index (BMI) itself, is associated with an increased risk of cardiovascular events [5, 6]. Serum retinol-binding protein 4 (RBP4) and prealbumin (PA) are considered objective indicators of nutritional status because changes in their levels reflect alterations in protein synthesis and metabolic health. RBP4 is also linked to insulin resistance and vitamin A metabolism. PA is a negative acute-phase protein whose levels decrease during inflammation and stress [7]. Despite numerous studies, it has not been possible to identify objective laboratory markers that can predict the future risk of vascular events in children [8]. Therefore, it seems that assessing the nutritional status and body composition of children with NS will allow for the introduction of appropriate dietary recommendations aimed at improving the nutritional status of children and reducing the risk of lifestyle diseases in the future (including atherosclerosis, cancer, and osteoporosis). However, detailed data on the nutritional status of these children is lacking. The aim of the current cross-sectional study was assessment of serum concentrations of retinol binding protein 4 (RBP4) and prealbumin (PA) selected as objective indicators of nutritional status, as well as the body composition parameters in children with NS in remission in comparison to healthy counterparts. Materials and methods The analysis included 44 subjects aged from 3.7 to 17.9 years (mean 11.1 ± 4.6 years), 63.6% were boys. The NS patients (NS, n = 30 children) were diagnosed and enrolled into this study at single regional medical centre for pediatric nephrology (Department of Nephrology, Upper Silesian Children’s Health Centre, Katowice) in the years 2023–2024. The group included children with NS who were in stable remission for at least 30 days. The exclusion criteria were: fewer than 30 days since the last significant treatment modification (change in medication to maintain remission) and coexisting kidney or gastrointestinal disease or other conditions that could affect the nutritional status, such as inflammatory bowel disease, food allergies or celiac disease. The control group (CG, n = 14) consisted of healthy children. Patients and controls were assessed similarly: in all subjects nutritional status was assessed using anthropometric measurements (body weight and height), bioimpedance testing and laboratory tests performed on a fasting blood sample. Height was measured on a stadiometer (Längenmeßtechnik GmbH Limbach-O, Germany). Based on Polish normative data, standard deviation scores (SDS) for weight, height and body mass index (BMI) were calculated [9]. The waist and hip circumference was measured in all patients, and then the waist-to-hip ratio (WHR) was calculated. All subjects underwent bioimpedance testing using the Tanita MC-980MA device (Tanita Health Equipment HK LTD, Hong Kong), and the assessed parameters were: fat mass, lean body mass, body cell mass and bone mass. Additionally, the ultrasound thickness of the intima-media complex (IMT) was measured for each participant by taking an average of three measurements at right carotid artery. Complete blood count (CBC), total cholesterol (TC), triglicerides, ferritin, ions, 25[OH]D, total protein and albumin levels were measured from both patients and controls by standard methods. Retinol-binding protein 4 (RBP4) determinations were performed using an ELISA method (IDK, Immundiagnostik AG, Germany). The kit included standard concentrations of 1.1–33 µg/L. Prealbumin (PA) determinations were performed using the ELISA method (IDK, Immundiagnostik AG, Germany) with standard concentrations included in the kit: 1.6–100 ng/mL. The medical history and data from the medical records of NS patients were also taken, including the duration of the disease and the course of treatment to date. Among the patients with NS, 16 children experienced rare relapses, 7 had frequent relapses (FRNS), and 7 were dependent on steroids (SDNS). 7 children required chronic treatment during the evaluation: 5 patients were treated with cyclosporine, one with mycophenolate mofetil, and one received both drugs simultaneously. The protocol of the research was approved in accordance with the Declaration of Helsinki by the Bioethical Committee of the Silesian Medical University in Katowice [resolution number PCN/CBN/0022/KB1/59/I/21/22], Poland. Patients and their guardians provided informed consent. Clinical characteristics of subjects studied is presented in Table 1. Table 1Clinical characteristics with selected laboratory parameters of children with NS and healthy controlsParameterNS children (n = 30)Controls (n = 14)P valueAge [years]11.9 ± 4.610.3 ± 4.2NSBody mass SDS-0.06 ± 1.13-0.28 ± 0.85NSHeight SDS-0.47 ± 1.08-0.12 ± 0.84NSBMI SDS0.19 ± 1.03-0.33 ± 0.86NSWaist-Hip Ratio0.90 ± 0.090.85 ± 0.11NSWBC [G/l]7.0 ± 1.97.2 ± 2.3NSHemoglobin [g/dl]13.3 ± 1.213.2 ± 0.8NSTIBC [ug/dl]376.9 ± 50.2366.5 ± 38.1NSVitamin D [ng/ml]27.1 ± 9.131.2 ± 8.8NSTotal cholesterol [mg/dl]169.3 ± 30.9169.9 ± 32.8NSTriglyceride [mg/dl]83.3 ± 41.478.9 ± 22.4NSTotal protein [g/l]70.1 ± 4.872.4 ± 3.2NSSerum albumin [g/l]44.5 ± 3.045.2 ± 2.3NSUric acid [mg/dl]5.1 ± 1.34.1 ± 0.9< 0.05Magnesium [mmol/l]0.82 ± 0.060.88 ± 0.07< 0.05 Table 1Clinical characteristics with selected laboratory parameters of children with NS and healthy controlsParameterNS children (n = 30)Controls (n = 14)P valueAge [years]11.9 ± 4.610.3 ± 4.2NSBody mass SDS-0.06 ± 1.13-0.28 ± 0.85NSHeight SDS-0.47 ± 1.08-0.12 ± 0.84NSBMI SDS0.19 ± 1.03-0.33 ± 0.86NSWaist-Hip Ratio0.90 ± 0.090.85 ± 0.11NSWBC [G/l]7.0 ± 1.97.2 ± 2.3NSHemoglobin [g/dl]13.3 ± 1.213.2 ± 0.8NSTIBC [ug/dl]376.9 ± 50.2366.5 ± 38.1NSVitamin D [ng/ml]27.1 ± 9.131.2 ± 8.8NSTotal cholesterol [mg/dl]169.3 ± 30.9169.9 ± 32.8NSTriglyceride [mg/dl]83.3 ± 41.478.9 ± 22.4NSTotal protein [g/l]70.1 ± 4.872.4 ± 3.2NSSerum albumin [g/l]44.5 ± 3.045.2 ± 2.3NSUric acid [mg/dl]5.1 ± 1.34.1 ± 0.9< 0.05Magnesium [mmol/l]0.82 ± 0.060.88 ± 0.07< 0.05 Clinical characteristics with selected laboratory parameters of children with NS and healthy controls Statistics Statistical analysis was performed, using the Statistica software (StatSoft, Tulsa, OK, USA). The mean values and standard deviations were used for descriptive statistics of continuous variables. The normality of data distribution was verified by the Shapiro-Wilk test. The Student’s t-test for independent samples or the Mann-Whitney U test was applied for comparative analyses of continuous variables, depending on data distribution. Correlation analyses were performed using Pearson’s method or Spearman’s test, depending on which was appropriate, according to the data distribution. Stepwise multiple linear regression was applied for multivariate analysis. The significance of results in all the statistical analyses was assumed at p < 0.05. Results The mean RBP4 serum concentration in the group of NS children was 42.6 ± 11.6 mg/l and did not differ significantly from that in the control group (42.0 ± 10.9 mg/l; p NS). The mean PA serum concentration in the group of NS children was 540.1 ± 442.1 µg/ml and did not differ significantly from that in the control group (372.8 ± 107.9 µg/ml; p NS). RBP4 concentration correlated positively with the age of the studied patients in the NS group (r = 0.48, p < 0.01) and also in the controls (r = 0.51, p < 0.05), while PA was not associated with age in both groups. Both studied markers did not show significant differences depending on the remission status – maintained with immunosuppressive therapy vs. without active treatment, as well as on the categorization according to the clinical course – steroid-sensitive NS vs. frequently relapsing or steroid-dependent NS. Based on bioimpedance measurements, selected parameters characterizing body composition were determined in the study and control groups. Detailed results are presented in Table 2. The results of ultrasound measurements of IMT in the carotid arteries are also included in the Table 2. Children in the NS group and the controls did not differ in these parameters. Table 2Body composition parameters based on bioimpedance measurements and IMT measurement results obtained in children with NS and healthy controlsParameterNS children (n = 30)Controls (n = 14)P valueLean body mass [kg]36.4 ± 15.128.8 ± 10.3NSFat [%]22.4 ± 10.622.9 ± 6.2NSFat mass [kg]9.9 ± 7.39.6 ± 6.7NSMuscle mass [kg]34.5 ± 14.427.3 ± 9.8NSBone mass [kg]1.9 ± 0.71.5 ± 0.5NSTotal body water [%]56.4 ± 9.956.8 ± 4.5NSIMT [mm]0.50 ± 0.080.51 ± 0.07NS Table 2Body composition parameters based on bioimpedance measurements and IMT measurement results obtained in children with NS and healthy controlsParameterNS children (n = 30)Controls (n = 14)P valueLean body mass [kg]36.4 ± 15.128.8 ± 10.3NSFat [%]22.4 ± 10.622.9 ± 6.2NSFat mass [kg]9.9 ± 7.39.6 ± 6.7NSMuscle mass [kg]34.5 ± 14.427.3 ± 9.8NSBone mass [kg]1.9 ± 0.71.5 ± 0.5NSTotal body water [%]56.4 ± 9.956.8 ± 4.5NSIMT [mm]0.50 ± 0.080.51 ± 0.07NS Body composition parameters based on bioimpedance measurements and IMT measurement results obtained in children with NS and healthy controls Next, correlation analysis was performed between the analyzed biochemical markers of nutritional status and selected other laboratory parameters and body composition analysis parameters. The results of these analyses are presented in Table 3. Table 3Correlation between analyzed biochemical markers of nutritional status with body composition variables and selected laboratory parametersParameterRBP4Prealbumin r p r p Fat-free mass0.46< 0.010.41< 0.01Fat0.16NS0.12NSFat mass0.27NS0.35< 0.05Muscle mass0.46< 0.010.41< 0.01Bone mass0.45< 0.010.41< 0.01Total body water-0.21NS-0.18NSIMT-0.13NS0.25NSWBC-0.45< 0.05-0.40< 0.05Hemoglobin0.52< 0.010.20NSTIBC0.44< 0.050.10NSVitamin D0.05NS-0.22NSTotal cholesterol-0.16NS-0.18NSTriglyceride0.29NS-0.07NSTotal protein0.31NS-0.06NSSerum albumin0.45< 0.05-0.17NSUric acid0.59< 0.010.20NSMagnesium0.36NS0.14NS Table 3Correlation between analyzed biochemical markers of nutritional status with body composition variables and selected laboratory parametersParameterRBP4Prealbumin r p r p Fat-free mass0.46< 0.010.41< 0.01Fat0.16NS0.12NSFat mass0.27NS0.35< 0.05Muscle mass0.46< 0.010.41< 0.01Bone mass0.45< 0.010.41< 0.01Total body water-0.21NS-0.18NSIMT-0.13NS0.25NSWBC-0.45< 0.05-0.40< 0.05Hemoglobin0.52< 0.010.20NSTIBC0.44< 0.050.10NSVitamin D0.05NS-0.22NSTotal cholesterol-0.16NS-0.18NSTriglyceride0.29NS-0.07NSTotal protein0.31NS-0.06NSSerum albumin0.45< 0.05-0.17NSUric acid0.59< 0.010.20NSMagnesium0.36NS0.14NS Correlation between analyzed biochemical markers of nutritional status with body composition variables and selected laboratory parameters Finally, a multivariate analysis was performed using the stepwise multiple regression method. In the final regression model, the following independent variables were identified as significantly associated with RBP4 concentration: serum uric acid, TIBC (total iron binding capacity), WBC (white blood cell count), albumin level and age. In the case of PA, these were: muscle mass, albumin level and WBC. The regression equations resulting from the obtained models are presented in Table 4. Table 4Regression equations for RBP4 and prealbumin obtained in Stepwise multiple linear regression models in NS childrenDependant variableRegression equationSSE R 2 RBP4-51.3 + 5.3xUA[mg/dl] + 0.1xTIBC [µg/dl] – 2.3xWBC [G/l] + 1.5xalbumin [g/l] -1.05xage[y.]± 7.80.62Prealbumin3189.6 + 16.0xmuscle mass [kg] -62.5xalbumin [g/l] – 59.4xWBC [G/l]± 365.50.39 Table 4Regression equations for RBP4 and prealbumin obtained in Stepwise multiple linear regression models in NS childrenDependant variableRegression equationSSE R 2 RBP4-51.3 + 5.3xUA[mg/dl] + 0.1xTIBC [µg/dl] – 2.3xWBC [G/l] + 1.5xalbumin [g/l] -1.05xage[y.]± 7.80.62Prealbumin3189.6 + 16.0xmuscle mass [kg] -62.5xalbumin [g/l] – 59.4xWBC [G/l]± 365.50.39 Regression equations for RBP4 and prealbumin obtained in Stepwise multiple linear regression models in NS children Discussion The results of our current study indicate that children with idiopathic NS do not differ significantly from healthy children in the remission phase in terms of selected biochemical markers of nutritional status – RBP4 and PA, nor do they demonstrate differences in parameters describing body composition measured using bioimpedance. This indicates that achieving a stable remission is also associated with the normalization of the biochemical markers and anthropometric parameters analyzed in this study. It was irrelevant whether the children in the study group were in remission without active treatment or in remission sustained with immunosuppressive therapy. These results shed favourable light on the efficacy and safety of currently available therapeutic methods used as a standard treatment in childhood NS. However, not all global reports are so favourable [10]. Our study result contrasts with the 10-year follow-up of a randomized controlled trial conducted by Ishikura et al. in Japan in 2015. Of the 46 patients, half were found to have poor nutrition or characteristics indicating an increased risk of cardiovascular disease, including short stature, obesity, bone mineralization disorders, and hypertension. However, it should be emphasized that all these patients had FRNS with the long-term relapsing nature and a complicated history of treatment [11]. The treatment used, as well as the increased incidence of obesity and hypertension in nephrotic patients described in the literature, may contribute to an increased risk of cardiovascular disease in adulthood. According to Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, children with hypertension and NS are at increased risk for dyslipidemia, left ventricle hypertrophy, left ventricular dysfunction, atherosclerosis, and aortic stiffness, all factors that have been associated with premature death in adults [12]. IMT is considered as a surrogate marker for the various cardiovascular events [13]. Previous studies have found greater IMT thickness among children with NS, and the thickness of the complex has positive correlation with age of children with NS, duration of disease, number of relapses, and higher BMI [14, 15]. The study found no difference in IMT thickness between the group of healthy children and the NS group. However, it is worth noting that, in recent years, changes in treatment standards have significantly reduced the period of steroid use, as well as the cumulative dose of steroids, which has reduced the number of complications in patients with NS [1, 11, 16, 17]. Regarding the biochemical markers, the importance of RBP4 in assessing metabolic disorders in the pediatric population has not been widely studied, and the literature examining this aspect in children with kidney disease is very sparse. The greatest attention has been devoted to RBP4 studies in the context of overweight, obesity, and metabolic syndrome, consistently demonstrating elevated levels of this protein in correlation with fat mass and simultaneously pointing to its potential role as a marker of future morbidity risk [18]. This marker has been demonstrated, among other things, to have predictive value in predicting non-alcoholic fatty liver disease [19]. Furthermore, a study conducted by Chinese authors in a large cohort of school children demonstrated the usefulness of RBP4 assessment in predicting the risk of metabolic syndrome over a ten-year period [20]. Given these results, the need for RBP4 assessment in children treated for NS is highly justified. We found no publications in the available literature that directly reference our results. Comparing our observations with studies on RBP4 in other pediatric medical problems, it can be concluded that, based on this useful marker of metabolic disorders, children with NS remaining in long-term remission do not present a high risk of long-term metabolic complications. PA is considered to be a sensitive marker of protein-energy nutritional status [21]. In conditions associated with chronically reduced protein-energy status, such as in patients with end-stage renal disease treated with peritoneal dialysis, its prognostic significance has been demonstrated in relation to mortality risk [22]. Generally, in the context of kidney disease, the diagnostic and predictive value of prealbumin has been most frequently studied in the context of impaired glomerular filtration. Reduced prealbumin levels are well documented in chronic kidney disease, especially in its end-stage stage [23]. Interestingly, the usefulness of assessing plasma prealbumin has also been studied in acute kidney injury, demonstrating the prognostic role of this parameter in relation to 90-day mortality [24]. Reduced PA levels and their association with an increased risk of poor prognosis have been also demonstrated in patients with childhood cancer by Milaniuk et al. [25]. The issue of PA variability in children with NS has also been little studied. In light of the available literature, our study assessing serum prealbumin levels in children in remission from NS is quite innovative. Furthermore, the stabilization of PA levels during remission at levels comparable to those in healthy children, demonstrated in our material, indicates favourable changes in nutritional status between the active period of NS and the remission phase. In our study, no differences were found between the groups in terms of lean body mass or other parameters measured by bioimpedance testing. Although assessment of lean body mass is a recognized method for identifying malnutrition, bioimpedance testing in patients with NS has only been used to assess fluid overload in children, according to the available literature [26, 27]. A significant reduction in muscle mass was found among adult patients with NS in remission compared to healthy patients [28]. There is little literature on this subject in children, but also confirms reduced muscle mass [29]. There is little research on the nutritional status of patients with nephrotic syndrome, not only in the remission phase, but also during metabolic decompensation due to proteinuria. Bioimpedance has been shown to be an effective method for assessing hyperhydration in patients with proteinuria, and reduced lean body mass has been reported during relapses [26–28]. Similarly, little literature is available on laboratory tests in the context of the parameters we studied during the proteinuria phase. While it is known that prealbumin levels are low, RBP4 concentrations have not been studied [28]. The last issue worth mentioning is the reliability of assessing nutritional status using biochemical markers. A meta-analysis published in 2000 assessed the role of biomarkers in describing the degree of malnutrition. The study included a total of 111 studies involving adults with various medical conditions. BMI and concentrations of albumin, hemoglobin, total cholesterol, prealbumin, and total protein in individuals at high risk of malnutrition were significantly lower than in those at low risk; however, after excluding patients with acute conditions, the predictive value of albumin and prealbumin decreased significantly, confirming the conclusion that they are more markers of inflammation than malnutrition [30]. Patients eligible for our study were in remission, without any current acute infectious conditions, so it seems that the results obtained are a reliable source of knowledge about nutritional status. Regarding the results of the multivariate analysis based on our study material, we can summarize that because the primary analysis did not reject the null hypothesis of no differences in RBP4 and PA concentrations between children with nephrotic syndrome in remission and their healthy peers, there was little expectation that the regression analysis would reveal clinically significant associations. However, the regression equations selected after analyzing the various models and presented in Table 4 indicate that among the variables associated with RBP4 and PA, other parameters reflecting aspects of nutritional status predominate: uric acid, TIBC, albumin concentration, and muscle mass. This result somewhat strengthens the rationale for selecting RBP4 and PA as potential markers of nutritional status in children with nephrotic syndrome. The study was conducted due to the limited data available on the nutritional status, body composition, and cardiovascular risk factors of children with NS. The results showed no difference in nutritional status between children with NS in remission and healthy children, which may be related to the modern treatment of NS, including shorter period of steroid treatment. The study has several limitations. The study group was small, and there was no assessment of cumulative steroid doses or long-term follow-up. However, the absence of differences in nutritional status between the groups suggests new areas for further observation, such as whether the results obtained are solely due to the treatment used or if patient education and awareness of diet, physical activity, and health promotion also played a role. Nevertheless, the results of our study suggest a broader application of selected biochemical markers related to nutritional status and non-invasive bioimpedance-based body composition analysis in assessing the clinical condition of children with NS. Further research in this area could offer the prospect of gathering knowledge that will allow for the assessment of the improvement process preceding remission. Potentially, such markers may also play a particularly important role in assessing the condition of patients with drug-resistant NS, who, while not achieving full remission, remain clinically stable but are characterized by a wide spectrum of disorders affecting the further development of these children. Conclusions RBP4 and PA, which can be considered as selected biochemical markers of nutritional status, do not indicate differences between children with remission of idiopathic NS and their healthy peers. Body composition analysis based on the bioimpedance method also does not reveal any differences between children in remission of NS and healthy children. Successful induction and maintenance of NS remission restores the assessed aspects of nutritional status of these patients, providing the opportunity for continued normal physical development of children affected by this clinical condition.